US Patent Issued to BEIJING TIDE PHARMACEUTICAL on April 7 for "P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition containing same, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,261, issued on April 7, was assigned to BEIJING TIDE PHARMACEUTICAL Co. LTD. (Beijing).

"P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition containing same, and use thereof" was invented by Yanping Zhao (Beijing), Hongjun Wang (Beijing), Yeming Wang (Beijing), Liying Zhou (Beijing) and Yanan Liu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a P2X3 and/or P2X2/3 receptor antagonist of formula (I), a pharmaceutical composition containing same, and the use thereof for preventing or treating a disease regulated by the P2X3 and/or P2X2/3 receptor antagonist."

The patent was filed on June 5, 2020, under Application...